AtriCure Reports First Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
AtriCure (ATRC) Tops Q1 EPS by 20c; Offers FY23 Revenue Guidance
May 2, 2023 4:05 PM EDTAtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.14), $0.20 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $93.5 million versus the consensus estimate of $87.53 million.
GUIDANCE:
AtriCure sees FY2023 revenue of $385-392 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
... More


